Johnson & Johnson remains a buy as business momentum accelerates, with Q4 revenue up 9.1% YoY and strong U.S. sales ...

As Johnson & Johnson seeks city incentives to help expand its Jacksonville-based vision products subsidiary, company officials are touting the growth potential of the unit.

Johnson & Johnson received approval from the Food and Drug Administration for a treatment for certain patients with multiple myeloma, an incurable form of blood cancer.

Morgan Stanley believes that Johnson and Johnson has stronger earnings potential driven by its robust product cycle. The bank ...

Johnson & Johnson (JNJ) is expected to announce a 21% jump in its fourth quarter earnings on January 21, before the bell.

Johnson & Johnson is set to report its Q4 results on Wednesday, facing one of the most important transitions in its modern ...

A Los Angeles jury awarded $40 million on Friday to two women who claimed that talcum powder made by Johnson & Johnson caused their ovarian cancer. The giant health care company said it would appeal ...

A California jury on Friday awarded $40 million to two women who said Johnson & Johnson‘s baby powder was to blame for their ovarian cancer. Erik Haas, Johnson & Johnson‘s worldwide vice president of ...

By Jonathan Stempel Jan 12 (Reuters) - Johnson & Johnson convinced Delaware's highest court to throw out part of a $1 billion damages award for breaching its 2019 agreement to buy Auris Health, a ...

A Minnesota jury awarded $65.5 million on Friday to a mother of three who claimed talcum products made by Johnson & Johnson exposed her to asbestos and contributed to her developing cancer in the ...

ST. PAUL, Minn. — A Minnesota jury awarded $65.5 million on Friday to a mother of three who claimed talcum products made by Johnson & Johnson exposed her to asbestos and contributed to her developing ...